Loading…
Acute Antibody-Mediated Rejection in Kidney Transplant Recipients
Abstract Antibody-mediated rejection has now been recognized as one of the most important causes of graft loss. Transplantation across HLA barriers and non-adherence can result in acute antibody-mediated rejection, which is associated with particularly worse graft outcomes. New technologies, includi...
Saved in:
Published in: | Transplantation reviews (Philadelphia, Pa.) Pa.), 2017-01, Vol.31 (1), p.47-54 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract Antibody-mediated rejection has now been recognized as one of the most important causes of graft loss. Transplantation across HLA barriers and non-adherence can result in acute antibody-mediated rejection, which is associated with particularly worse graft outcomes. New technologies, including genomic studies and assays to detect and define donor-specific antibodies, have provided important insights into the pathophysiology and diagnosis of acute antibody-mediated rejection but have engendered many questions about the clinical application of these tests in the prognosis and prevention of this protean disease process. In this article, we review the pathophysiology of acute antibody-mediated rejection, the evolving diagnostic criteria, and specific challenges related to its prognosis, treatment, and prevention. |
---|---|
ISSN: | 0955-470X 1557-9816 |
DOI: | 10.1016/j.trre.2016.10.004 |